InventisBio Co., Limited (SHA:688382)
19.99
+2.08 (11.61%)
At close: Mar 27, 2026
InventisBio Revenue
In the year 2025, InventisBio had annual revenue of 37.33M CNY, down -77.89%. InventisBio had revenue of 6.43M in the quarter ending December 31, 2025, a decrease of -95.70%.
Revenue
37.33M
Revenue Growth
-77.89%
P/S Ratio
309.74
Revenue / Employee
201.76K
Employees
168
Market Cap
11.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 37.33M | -131.47M | -77.89% |
| Dec 31, 2024 | 168.79M | -16.74M | -9.02% |
| Dec 31, 2023 | 185.53M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 16.62B |
| Chengzhi | 11.53B |
| Tibet Cheezheng Tibetan Medicine | 2.42B |
| Pacific Shuanglin Bio-pharmacy | 2.38B |
| Aurisco Pharmaceutical | 1.62B |
| Chengdu Easton Biopharmaceuticals | 1.33B |
| Jiangxi Fushine Pharmaceutical | 1.18B |
| Hualan Biological Vaccine | 976.44M |